Free Access
Med Sci (Paris)
Volume 21, Décembre 2005
Métabolisme glucidolipidique et risque cardiovasculaire: Nouvelle approches
Page(s) 40 - 42
Section M/S revues
Published online 15 November 2005
  1. Fabry J. Ein Beitrag zur Kenntnis der Purpura haemorrhagica nodularis (Purpura papulosa hemorrhagica Hebrae). Arch Dermatol Syphilol 1898; 43 : 187–200. [Google Scholar]
  2. Anderson W. A case of Angeio-keratoma. Br J Dermatol 1898; 10 : 113–7. [Google Scholar]
  3. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder : expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138 : 338–46. [Google Scholar]
  4. Germain DP. La maladie de Fabry. Aspects cliniques et génétiques. Perspectives thérapeutiques. Rev Med Interne 2000; 21 : 1086–103. [Google Scholar]
  5. Mahé E, Hadj-Rabia S, Chauveau D, et al. Maladie de Fabry. Place du dermatologue et progrès thérapeutique. Ann Dermatol Venereol 2005; 132 : 171–6. [Google Scholar]
  6. Mehta A, Ricci R, Widmer U, et al. Fabry disease defined : baseline clinical manifestation of 366 patients in the Fabry outcome survey. Eur J Clin Invest 2004; 34 : 236–42. [Google Scholar]
  7. Kanekura T, Fukushige T, Tsuyama S, et al. Immunoelectron-microscopic detection of globotriaosylceramide accumulated in the skin of patients with Fabry disease. Br J Dermatol 2005; 153 : 544–8. [Google Scholar]
  8. Kang WH, Chun SI, Lee S. Generalized anhidrosis associated with Fabry’s disease. J Am Acad Dermatol 1987; 17 : 883–7. [Google Scholar]
  9. Kanitakis J, Allombert C, Doebelin B, et al. Fucosidosis with angiokératome. Immunohistochemical and electronmicroscopic study of a new case and literature review. J Cutan Pathol 2005; 32 : 506–11. [Google Scholar]
  10. Linthorst GE, De Rie MA, Tjiam KH, et al Misdiagnosis of Fabry disease : importance of biochemical confirmation of clinical or pathological suspicion. Br J Dermatol 2004; 150 : 575–7. [Google Scholar]
  11. Masouyé I, Saurat JH. Angiokératomes. In : Dermatologie et infections sexuellement transmissibles, 4e ed. Paris : Masson, 2004 : 723–5. [Google Scholar]
  12. Fordyce JA. Angiokeratoma of the scrotum. J Cutan Dis 1896; 14 : 81–9. [Google Scholar]
  13. Kim Y, Dawes-Higgs E, Mann S, et al. Acral pseudolymphomatous angiokeratoma of children (APACHE). Australas J Dermatol 2005; 46 : 177–80. [Google Scholar]
  14. Degos R. Angiokératose circonscrite næviforme (Fabry II). Angiome serpigineux (Hutchinson). In : Dermatologie. Paris : Flammarion Médecine-Sciences, 1980 : 774 p. [Google Scholar]
  15. Gorse SJ, James W, Murison MSC. Successful treatment of angiokeratoma with potassium tritanyl phosphate laser. Br J Dermatol 2004; 150 : 620–2. [Google Scholar]
  16. Möhrenschlager M, Henkel V, Ring J. Fabry disease. More than angiokeratomes. Arch Dermatol 2004; 140 : 1526–8. [Google Scholar]
  17. Ries M, Schiffmann R. Fabry disease : angiokeratoma, biomarker and the effect of enzyme replacement therapy on kidney function. Arch Dermatol 2005; 141 : 904–5. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.